- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- Pre-launch efforts linked to lasting drug awareness edge: report
- AHA: Cyber resilience critical to prevent nation-state hacks
- Elevance senior executive fights DOJ deposition bid in Medicare Advantage fraud case
- A split is emerging in healthcare’s workforce pipeline
- The hospitals, health systems cutting jobs in 2026
- 19 women making moves in healthcare
- Judy Faulkner’s long game: An Epic that no one can buy
- Why WakeMed’s CEO says his system will ‘survive’ but not ‘thrive’ alone
- NYC invests $12M in overdose recovery workforce
- Epic’s biggest moves in 2026 so far
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Providence raises $500M in philanthropy in 2025
- New York system opens outpatient pavilion
- ‘We cannot cut our way to success’: Hospitals prep for Medicaid crunch
- What cardiology ASCs still haven’t mastered
- Texas dental practice relocates into 6K-square-foot facility
- Surgery Partners opens 9 ASCs in 12 months amid ‘fickle’ M&A market
- Medit launches global orthodontics division, acquires California training institute
- What’s going on behind ASC de novo development?
- Pennsylvania enacts dental faculty bill
- Payer denials remain elevated, but aren’t accelerating: Tenet
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Arkansas dental school launches partnership with children’s hospital
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Woodside Health acquires 40K-square-foot MOB
- Remarks at the 13th Annual Conference on Financial Market Regulation
- Eko Health appoints cardiologist as chief medical officer
- 5 best practices for financially integrating behavioral health
- North Carolina physician practice acquired
- Straine Dental unifies 3 operating companies under single brand
- Thomas Jefferson University to launch new nurse anesthesia program
- Inside this state’s ‘evolving’ noncompete policy
- Is dentistry losing its spark?
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Nebraska Medicaid patients struggle to access care as dentists drop out: 6 notes
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Kaiser Permanente eases ‘last mile to licensure’ for mental health workers
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- Cannabis most commonly microdosed substance in US: Study
- FDA Authorizes Fruit-Flavored Vapes for Adults
- White House outlines drug control strategy: What healthcare leaders should know
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Newly formed Keenova launches ‘Don't Be a Viking’ campaign for Dupuytren’s contracture
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- Healthcare Dealmakers—UConn Health grows, Centene subsidiaries merge and more
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Confusion Continues Over Age To Start Breast Cancer Screening, Survey Finds
The Michigan Department of Agriculture and Rural Development (MDARD) and MDHHS are warning against online purchases of unregistered pesticides containing organophosphate dichlorvos (DDVP), specifically “Sniper” and “Nopest”. These insecticides destroy nervous system functioning, just as military nerve gasses do. Neither Michigan department explains the meaning of registration in this joint press release, but I think they are referring to Agency for Toxic Substances and Disease Registry (ATSDR) registration:
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2026/02/09/ddvp-warning
https://www.michigan.gov/mdard/plant-pest/pesticides
MDHHS and MDARD urge residents to use caution when buying and using pesticides
By Lynn Sutfin - February 09, 2026Recent poisonings due to pesticides containing dichlorvos prompt warning
LANSING, Mich. – The Michigan Department of Health and Human Services (MDHHS) and Michigan Department of Agriculture and Rural Development (MDARD) are warning residents to avoid purchasing unregistered pesticides containing dichlorvos (DDVP), including brand names “Sniper” and “Nopest.”
Despite their potentially harmful health effects, “Sniper” and “Nopest” remain available for purchase via online marketplaces, where they are marketed as insecticides for home use. These and other pesticides that contain highly concentrated DDVP are responsible for recent poisonings in Michigan. Consumers should be aware that not all pesticides purchased online are registered by the U.S. Environmental Protection Agency (EPA) or are safe to use at home. Neither “Sniper” or “Nopest” are registered by EPA.
“These recent cases are a serious reminder that unregistered or illegal pesticide products can pose significant risks to public health,” said MDARD Director Tim Boring. “MDARD urges residents to take simple steps, such as checking for an EPA registration number and following label directions, to protect themselves, their families and the environment.”
Pesticides are any substance used to kill or repel pests to reduce the damage they cause. They include disinfectants, fungicides, insecticides, herbicides and animal repellants.
If you become sick after being exposed to pesticides, contact Poison Control at 800-222-1222 or call your health care provider. If you become severely ill or have a hard time breathing, call 911 or go to the emergency room.
“We urge Michigan residents to use precaution when using pesticides to prevent harm to themselves, their family or pets,” said Dr. Natasha Bagdasarian, chief medical executive. “If you suspect pesticide poisoning, move to fresh air, remove any contaminated clothing, wash skin with soap and water, and seek medical attention.”
Pesticide poisoning symptoms include:
- Eye, nose and/or throat irritation.
- Headache.
- Nausea.
- Seizures.
- Shortness of breath.
- Skin irritation.
- Coma.
- Death.
Risk of pesticide poisoning depends on the following:
- Toxicity.
- Length of exposure.
- Amount of pesticide.
- Type of exposure, such as breathing it in, getting it in the eyes or on the skin, or eating or drinking it.
To avoid serious injury or illness when using pesticides:
- Purchase pesticides with an EPA Registration Number (“EPA Reg. No.”) and an EPA Establishment Number (“EPA Est. No.”) on the label. These are tested to make sure they do not cause major risks to human health or the environment when used as directed.
- Read and follow the label. Following label directions is the only safe way to use a pesticide.
- Wear required protective clothing and equipment such as gloves, eye protection or masks.
- Do not spray pesticides outdoors when it is windy.
- Wipe, rather than spray, disinfectant products indoors.
- Wash hands and clothing after using pesticides.
- Store pesticides in a safe place away from children and pets.
Residents who discover they have unregistered pesticides in their possession should immediately dispose of these products using the following steps:
- Wear protective clothing, gloves and a face mask, and double bag the bottle or container in heavy plastic.
- Add sand, dirt or kitty litter to the bag, if possible, especially if the bottle is leaking.
- Contact the local waste management company to find out where to safely dispose of the container.
- Do not let children or pets near the pesticide.
- Do not pour the pesticide down the drain.
Pesticide poisoning in Michigan
Since 2001, there have been three confirmed unintentional pesticide-related deaths. While deaths from pesticides are rare, more than 2,700 total confirmed pesticide illnesses or injuries were reported in the past decade.
For more information about pesticides, visit:
MDHHS pesticide illness webpage
MDARD pesticides webpage
Pesticides are also a health issue at the national level, in the USDA "farm bill":
https://thehill.com/policy/energy-environment/5737733-farm-bill-pesticides-maha/
In farm bill, GOP takes another swing at pesticide protections loathed by MAHA
By Rachel Frazin - February 13, 2026Republicans are using the farm bill to take another swing at passing legislation to protect pesticides, something sure to anger their allies in the “Make America Healthy Again” (MAHA) movement.
A House Republican iteration of the farm bill released on Friday includes a provision that prevents states and courts from penalizing pesticide makers for failing to include warnings on their label about health effects that go beyond those formally recognized by the Environmental Protection Agency (EPA).
Proponents of such measures say they prevent companies from having to comply with a hodgepodge of rules that could differ from place to place.
However, opponents of such language argue that it could be used to tamp down on failure-to-warn lawsuits that seek to hold pesticide companies accountable for not disclosing alleged harms of their products.
Similar language was ultimately removed from an EPA appropriations package earlier this year amid pushback from Democrats and MAHA-aligned Republicans.
The MAHA movement has been spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr. Its members are largely skeptical of big business, including Big Pharma, Big Ag and Big Chemical — breaking with other Republicans who are often big business allies.
While the measure applies to pesticides broadly, the issue is often talked about in terms of glyphosate, which has been a key ingredient in the weedkiller Roundup.
While the EPA says there’s “insufficient evidence to conclude that glyphosate plays a role in any human diseases,” multiple lawsuits have claimed otherwise — and have cost Bayer billions of dollars.
The question of whether such lawsuits are preempted under federal law will be reviewed by the Supreme Court this year.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















